All results
20 results for observational study hepatitis c virus pregnancy
-
CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis
This is a Phase 2, multicenter, multinational, randomized, double-blind, placebo-controlled study evaluating the efficacy, safety, pharmacokinetics (PK),…
- Ages
- 40 Years - N/A
- Sexes
- All
-
ARGX-113-2007
This study's purpose is to measure the treatment response from efgartigimod PH20 SC compared with placebo in participants with Idiopathic Inflammatory Myopathy…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Camostat Mesilate
The purpose of this study is to determine the safety and efficacy of NI-03. The primary objective of the Single-Dose Phase is to assess the pharmacokinetics…
- Ages
- 18 Years - 85 Years
- Sexes
- All
-
Oral IRAK-4 inhibitor CA-4948 in combination with Pembrolizumab following stereotactic radiosurgery
This phase I/II trial will investigate the use of the novel oral IRAK-4 inhibitor CA-4948 in combination with pembrolizumab therapy following stereotactic…
- Ages
- 18 Years - 99 Years
- Sexes
- All
-
A Study of ASP1002 in Adults for Treatment of Solid Tumors
ASP1002 is a potential new treatment for people with certain solid tumors. Before ASP1002 is available as a treatment, the researchers need to understand how…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Testing Triapine w/ Targeted Radiation-based LU177 vs Lu177 alone in pts w/ metastatic NETs
This phase II trial compares the effect of adding triapine to lutetium Lu 177 dotatate versus lutetium Lu 177 dotatate alone (standard therapy) in shrinking…
- Ages
- 18 Years - N/A
- Sexes
- All
-
TN-31 JAKPOT T1D
A multi-center, placebo-controlled, double blind, 1:1:1 randomized control clinical trial testing two different JAK Inhibitors abrocitnib, ritlecitinib, and…
- Ages
- 12 Years - 35 Years
- Sexes
- All
-
Compare Chemo Before and After Surgery vs After Surgery Alone for the TX of Gallbladder Cancer
This phase II/III trial compares the effect of adding chemotherapy before and after surgery versus after surgery alone (usual treatment) in treating patients…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Addition of Pembrolizumab to Usual Intravesical Gemcitabine for Treatment of BCG-Unresponsive NMIBC
This phase II trial studies the effect of adding pembrolizumab to gemcitabine in treating patients with non-muscle invasive bladder cancer whose cancer does…
- Ages
- 18 Years - N/A
- Sexes
- All
-
u-STOP LVAD Bleed
This is a Phase I, single ascending dose, first in human, open-label, non-controlled, dose-escalation trial that will investigate intravenous infusions of…
- Ages
- 18 Years - 80 Years
- Sexes
- All